Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The majority of men with congenital absence of the vas deferens have a defect in both copies of the CFTR gene and therefore represent a distinct phenotypic form of cystic fibrosis.
|
8796848 |
1996 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a genetic and life-limiting disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.
|
31715088 |
2019 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residue at position 508 in CFTR (ΔF508-CFTR) protein.
|
24818864 |
2014 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is due to a folding defect in the CF transmembrane conductance regulator (CFTR) protein.
|
25384981 |
2014 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The most common mutation of CFTR, affecting approximately 90% of CF patients, is a deletion of phenylalanine at position 508 (F508del, ΔF508).
|
26863533 |
2016 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
|
10762539 |
2000 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
The p.Gly622Asp (G622D) mutation, frequently found in Reunion Island and in black populations, is associated with a wide spectrum of CF and CFTR-RD phenotypes.
|
25443471 |
2015 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is inherited as an autosomal recessive trait, and the mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene contributes to the CF syndrome.
|
15716623 |
2005 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Sec16A is critical for both conventional and unconventional secretion of CFTR.
|
28067262 |
2017 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
It has been shown that the CBAVD in men without clinical evidence of CF is associated with a high incidence of mutated CFTR (cystic fibrosis transmembrane conductance regulator) alleles.
|
15905293 |
2005 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Thus reduced Cl- conductance caused by the three CFTR mutations affects normal development of vas deferens and leads to CBAVD, but the remaining function is sufficient to prevent other typical CF symptoms.
|
18769034 |
2008 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
|
15480987 |
2004 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Identification of six novel CFTR mutations in a sample of Italian cystic fibrosis patients.
|
7541510 |
1995 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains.
|
1382316 |
1992 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis.
|
18556774 |
2008 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is caused by mutations in the gene encoding for the CF transmembrane conductance regulator (CFTR) protein, which acts as a chloride channel after activation by cyclic AMP (cAMP).
|
17018149 |
2006 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In order to define the CFTR genotype a series of 1812 individuals from central-southern Italy with and without CF manifestations were screened by using the PCR/OLA assay.
|
16379540 |
2005 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients.
|
24586523 |
2014 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis is an inherited disorder of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that affects the respiratory system.
|
30171436 |
2019 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
A novel mutation in the CFTR gene correlates with severe clinical phenotype in seven Hispanic patients.
|
10777364 |
2000 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Ivacaftor acts as a potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) and increases the transepithelial chloride transport of CFTR in 9 of 10 known gating mutations causing cystic fibrosis.
|
26474553 |
2015 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is a multiorgan, genetic disease resulting from dysfunction of the CF transmembrane conductance regulator.
|
30077689 |
2019 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cystic fibrosis (CF) is due to mutations in the CFTR gene and is characterized by hypersecretion of the proinflammatory chemokine IL-8 into the airway lumen.
|
19363120 |
2009 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We provide evidence that combination lumacaftor and ivacaftor improves FEV1 for patients with cystic fibrosis who are homozygous for phe508del CFTR, with a modest effect on sweat chloride concentration.
|
24973281 |
2014 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The novel complex allele [A238V;F508del] of the CFTR gene: clinical phenotype and possible implications for cystic fibrosis etiological therapies.
|
26911355 |
2016 |